Skip to content
Disclosery

EXANE DERIVATIVES: DUK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on DUK, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 2,135 DUK shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 2,135 shares
    Change vs previous 13F -179 shares

    0.13% of the 13F portfolio, value $228,869.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 2,314 shares
    Change vs previous 13F -1,119 shares

    0.07% of the 13F portfolio, value $258,383.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 3,433 shares
    Change vs previous 13F -686 shares

    0.09% of the 13F portfolio, value $360,133.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 4,119 shares
    Change vs previous 13F -467 shares

    0.1% of the 13F portfolio, value $401,989.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 4,586 shares
    Change vs previous 13F +2,502 shares

    0.11% of the 13F portfolio, value $465,627.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 2,084 shares
    Change vs previous 13F +242 shares

    0.06% of the 13F portfolio, value $201,178.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 1,842 shares
    Change vs previous 13F +260 shares

    0.05% of the 13F portfolio, value $168,661.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 1,582 shares
    Change vs previous 13F not available

    0.05% of the 13F portfolio, value $140,106.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).